{"id":"75617941310-89","name":"Johnson &amp; Johnson","registrationDate":"2009-03-06T13:12:24.858+01:00","category":2,"subCategory":3,"legal":"Corporation","web":"http://www.jnj.com","country":"United states","headAddress":"Johnson &amp; Johnson Plaza, One","headCity":"New Brunswick, New Jersey","headPostCode":"08933","headPhone":"(1732)5 24 04 00","boss":"Alex Gorsky","bossTitle":"Mr","bossPosition":"Chairman and CEO","membersCount":17,"membersFTE":"5.75","membership":"EFPIA, Cosmetics Europe, MedTech Europe, AmCham EU/BE, BritCham, EBE, EVM, COCIR, AESGP, Euromcontact, EJF, CSR Europe, EASSI, AIM, EDANA, EDMA, NIA, EPC Global, the EPC, EPAA, EU40.","memberOrga":"","goal":"Johnson &amp; Johnson embraces research and science, bringing innovative ideas, products and services to advance the health and well-being of people.  Its family of companies consists of more than 265 operating companies in 60 countries, with products sold for the consumer healthcare, pharmaceutical and medical devices and diagnostics markets.","acronym":"J&amp;J","interests":"Climate Action, Competition, Consumer Affairs, Customs, Development, Economic and Financial Affairs, Employment and Social Affairs, Enlargement, Enterprise, Environment, Food Safety, General and Institutional Affairs, Humanitarian Aid, Information Society, Internal Market, Justice and Fundamental Rights, Public Health, Research and Technology, Taxation, Trade","euInitiatives":"Cosmetics legislation and policy; selfcare; REACH, RoHs, WEEE, EEE, Medical devices Review, In Vitro Diagnostics Review, Clinical Trials legislation, Falsified Medicines, Transparency legislations, chemicals; environmental initiatives, climate change, Research, competitiveness of industrial sectors, Prevention and lifestyle, Vaccines; IMI2; Trade: CETA, TTIP, EU-Japan, EU India;","lastUp":"2017-10-27T14:07:45.306+01:00","customers":"","costAbsolu":"","costRange":"1750000-1999999","turnoverAbsolu":0,"turnoverRange":""}